An electroacoustic analysis of over-the-counter hearing aids

American Journal of Audiology

Volumn 17, Issue 1, 2008, Pages 14-24

  Callaway, Susanna Løve ^a   Punch, Jerry L ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Electroacoustic characteristics; NAL SSPL; National acoustic laboratories revised; Over the counter hearing aids; Special purpose hearing aids

Indexed keywords

ACOUSTICS; ANALYTIC METHOD; ARTICLE; AUDIOMETRY; COST; ELECTROACOUSTIC ANALYSIS; EVALUATION; HAZARD; HEARING AID; HEARING LOSS; MATERIALS TESTING; NATIONAL ACOUSTIC LABORATORIES REVISED PROCEDURE; NOISE; SAFETY; STANDARD;

CONSUMER SATISFACTION; HEARING AIDS; HUMANS; PROSTHESIS DESIGN; SPEECH ACOUSTICS;

EID: 46949096497     PISSN: 10590889     EISSN: None     Source Type: Journal    
DOI: 10.1044/1059-0889(2008/003)     Document Type: Article

References (22)

1. American National Standards Institute. (1987). Specification of hearing aid characteristics (ANSI S3.22-1987). New York: Author.
2. American National Standards Institute. (1996). Specification of hearing aid characteristics (ANSI S3.22-1996). New York: Author.
3. Buuren, R. A., Festen, J. M., & Houtgast, T, (1996). Peaks in the frequency response of hearing aids. Journal of Speech and Hearing Research, 39, 239-250.
4. Byrne, D., & Dillon, H. (1986). The National Acoustic Laboratories' (NAL) new procedure for selecting the gain and frequency response of a hearing aid. Ear & Hearing, 7, 257-265.
5. Cheng, C. M., & McPherson, B. (2000). Over-the-counter hearing aids: Electroacoustic characteristics and possible target client groups. Audiology, 39(2), 110-116.
6. Dillon, H. (2001). Hearing aids. New York: Thieme.
7. Kasper, C. A., Spitzer, J. B., & Rodriguez, H. (1999). Mailorder hearing aids and patient safety: A case study. The Hearing Journal, 52(1), 41-44.
8. Killion, M. C. (1993). The K-Amp hearing aid: An attempt to present high fidelity for persons with impaired hearing. American Journal of Audiology, 2, 52-74.
9. Killion, M. (2003). Citizen petition to the Food & Drug Administration, August 7, 2003. Petition #2003P-0362. Retrieved May 6, 2007, from www.fda.gov/ohrms/dockets/dailys/03/aug03/081203/03p-0362-cp00001 -voll.pdf.
10. Kochkin, S. (2002). MarkeTrak VI: Consumers rate improvements sought in hearing instruments. The Hearing Review, 9(11), 18-22.
11. Kuk, F., Keenan, D., & Ludvigsen, C. (2003). Changing with the times: Managing low-frequency hearing loss. The Hearing Review, 70(12), 32-37, 52.
12. McPherson, B., & Wong, E. T. L. (2005). Effectiveness of an affordable hearing aid with elderly persons. Disability and Rehabilitation, 27, 601-609.
13. Moore, B. C., Stone, M. A., & Alcantara, J. I. (2002). Comparison of the electroacoustic characteristics in five hearing aids. International Journal of Audiology, 41, 371-373.
14. Parving, A. (2003). The hearing aid revolution: Fact or fiction? Acta Otolaryngologica, 123, 245-248.
15. Parving, A., & Christensen, B. (2004). Clinical trial of a low-cost solar-powered hearing aid. Acta Otolaryngologica, 124, 416-420.
16. Parving, A., Christensen, B., Nielsen, J., & Konradsson, K. (2005). Clinical trial of low-cost, high power compression hearing aid. Audiological Medicine, 3(2), 76-81.
17. Punch, J. L. (1987). Matching commercial hearing aids to prescriptive gain and maximum output requirements. Journal of Speech and Hearing Disorders, 52, 76-83.
18. Staab, W. J. (2002). Characteristics and use of hearing aids. In J. Katz (Ed.), Handbook of clinical audiology (5th ed., pp. 631-686). Philadelphia: Lippincott Williams & Williams.
19. Storey, L., Dillon, H., Yeend, I., & Wigney, D. (1998). The National Acoustic Laboratories' procedure for selecting the saturation sound pressure level of hearing aids: Experimental validation. Ear & Hearing, 19, 267-279.
20. Sweetow, R. W. (2001). An analysis of entry-level, disposable, instant-fit, and implantable hearing aids. The Hearing Journal, 54(2), 28-42.
21. U.S. Food and Drug Administration. (2007a). Subpart Dprosthetic devices. Retrieved May 6, 2007, from www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfcfr/CFRSearch. cfm?CFRPart=874&showFR=1&subpartNode=21:8.0.1.1. 23.4.
22. U.S. Food and Drug Administration. (2007b). Testimony on FDA's Medical Device Program by Michael Friedman, M.D. Retrieved May 6, 2007, from www.hhs.gov/asl/testify/t970430a.html.